Financials

  • Market Capitalization 4.39 B
  • Employee 838
  • Founded 2014
  • CEO Mark Crossley
  • Website www.indivior.com
  • Headquarter Delaware, United States
  • FIGI BBG01ZTXFLQ6
  • Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.63
市销率
3.02

Indivior Pharmaceuticals, Inc. - Common Stock

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

新闻